Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study

References

• Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343(13):938–952. doi:10.1056/NEJM200009283431307
   PubMed Web of Science ®Google Scholar
• Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol. 2019;26(1):27–40. doi:10.1111/ene.13819
   PubMed Web of Science ®Google Scholar
• Benito-Leon J, Morales JM, Rivera-Navarro J, Mitchell A. A review about the impact of multiple sclerosis on health-related quality of life. Disabil Rehabil. 2003;25(23):1291–1303. doi:10.1080/09638280310001608591
   PubMed Web of Science ®Google Scholar
• Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? PharmacoEconomics. 2016;34(7):645–649. doi:10.1007/s40273-016-0389-9
   PubMed Web of Science ®Google Scholar
• Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health. 2004;7(2):204–215. doi:10.1111/j.1524-4733.2004.72252.x
   PubMed Web of Science ®Google Scholar
• Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health. 2005;8(Suppl 1):S9–S24. doi:10.1111/j.1524-4733.2005.00066.x
   PubMed Web of Science ®Google Scholar
• Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci. 2002;205(1):51–58. doi:10.1016/S0022-510X(02)00312-X
   PubMed Web of Science ®Google Scholar
• Berrigan LI, Fisk JD, Patten SB, et al. Health-related quality of life in multiple sclerosis: direct and indirect effects of comorbidity. Neurology. 2016;86(15):1417–1424. doi:10.1212/WNL.0000000000002564
   Web of Science ®Google Scholar
• Nourbakhsh B, Julian L, Waubant E. Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study. Eur J Neurol. 2016;23(9):1482–1486. doi:10.1111/ene.13102
   PubMed Web of Science ®Google Scholar
• Mekies C, Heinzlef O, Jenny B, Ramelli AL, Clavelou P. Treatment satisfaction and quality of life in patients treated with fingolimod. Patient Prefer Adherence. 2018;12:899–907. doi:10.2147/PPA.S144021
   Web of Science ®Google Scholar
• Haase R, Kullmann JS, Ziemssen T. Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey. Ther Adv Neurol Disord. 2016;9(4):250–263. doi:10.1177/1756285616634247
   PubMed Web of Science ®Google Scholar
• Barbosa CD, Balp MM, Kulich K, Germain N, Rofail D. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012;6:39–48. doi:10.2147/PPA.S24752
   PubMed Web of Science ®Google Scholar
• Saiz A, Mora S, Blanco J. Treatment compliance with first line disease-modifying therapies in patients with multiple sclerosis. Compliance study. Neurol (English Edition). 2015;30(4):214–222. doi:10.1016/j.nrleng.2015.03.003
   PubMed Web of Science ®Google Scholar
• Grytten N, Aarseth JH, Espeset K, et al. Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis–a multicentre cohort study. Acta Neurol Scand Suppl. 2012;126(195):51–57. doi:10.1111/ane.12033
   Google Scholar
• Steinberg SC, Faris RJ, Chang CF, Chan A, Tankersley MA. Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study. Clin Drug Investig. 2010;30(2):89–100. doi:10.2165/11533330-000000000-00000
   PubMed Web of Science ®Google Scholar
• Khurana V, Sharma H, Afroz N, Callan A, Medin J. Patient-reported outcomes in multiple sclerosis: a systematic comparison of available measures. Eur J Neurol. 2017;24(9):1099–1107. doi:10.1111/ene.13339
   PubMed Web of Science ®Google Scholar
• Ting J, Liu Y, Petrillo J, Giannattasio G, Sabatella G. Treatment satisfaction with disease modifying therapies in multiple sclerosis: a systematic review of studies using the treatment satisfaction questionnaire for medication (Tsqm). Value Health. 2015;18(7):A760–A761. doi:10.1016/j.jval.2015.09.2484
   Web of Science ®Google Scholar
• Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol. 2005;58(6):840–846. doi:10.1002/ana.20703
   PubMed Web of Science ®Google Scholar
• DGN/KKNMS. German Neurological Society (DGN). Leitlinie zur Diagnose und Therapie der MS [Guidelines for MS Diagnosis and Treatment]. 2014.
   Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–1452. doi:10.1212/WNL.33.11.1444
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User’s Manual for the SF-36v2 Health Survey. 2nd ed. Quality Metric Lincoln (RI); 2007.
   Google Scholar
• Morfeld M, Bullinger M, Nantke J, Brahler E. Die version 2.0 des SF-36 health survey: ergebnisse einer bevölkerungsrepräsentativen Studie [The version 2.0 of the SF-36 Health Survey: results of a population-representative study]. Soz Praventivmed. 2005;50(5):292–300. doi:10.1007/s00038-005-4090-6
   Google Scholar
• Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2(1):12. doi:10.1186/1477-7525-2-12
   PubMedGoogle Scholar
• Vermersch P, Hobart J, Dive-Pouletty C, Bozzi S, Hass S, Coyle PK. Measuring treatment satisfaction in MS: is the treatment satisfaction questionnaire for medication fit for purpose? Mult Scler (Houndmills, Basingstoke, England). 2017;23(4):604–613. doi:10.1177/1352458516657441
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edn. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
   Google Scholar
• Walters SJ, Campbell MJ. The use of bootstrap methods for analysing health-related quality of life outcomes (particularly the SF-36). Health Qual Life Outcomes. 2004;2(1):70. doi:10.1186/1477-7525-2-70
   Google Scholar
• Gignac GE, Szodorai ET. Effect size guidelines for individual differences researchers. Pers Individ Dif. 2016;102:74–78. doi:10.1016/j.paid.2016.06.069
   Web of Science ®Google Scholar
• Biggs D, De Ville B, Suen E. A method of choosing multiway partitions for classification and decision trees. J Appl Stat. 1991;18(1):49–62. doi:10.1080/02664769100000005
   Google Scholar
• Meulman J, Heiser W. IBM SPSS categories 21; 2012. Available from: ftp://public.dhe.ibm.com/software/analytics/spss/documentation/statistics/21.0/en/client/Manuals/IBM_SPSS_Categories.pdf.
   Google Scholar
• Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc B Methodol. 1996;58(1):267–288. doi:10.1111/j.2517-6161.1996.tb02080.x
   Google Scholar
• Walter S, Tiemeier H. Variable selection: current practice in epidemiological studies. Eur J Epidemiol. 2009;24(12):733–736. doi:10.1007/s10654-009-9411-2
   PubMed Web of Science ®Google Scholar
• Ellert U, Kurth BM. Health related quality of life in adults in Germany: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(5–6):643–649. doi:10.1007/s00103-013-1700-y
   PubMed Web of Science ®Google Scholar
• Asadi-Lari M, Tamburini M, Gray D. Patients’ needs, satisfaction, and health related quality of life: towards a comprehensive model. Health Qual Life Outcomes. 2004;2(1):32. doi:10.1186/1477-7525-2-32
   PubMedGoogle Scholar
• Amtmann D, Bamer AM, Kim J, Chung H, Salem R. People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and NeuroQoL outcome measures. Disabil Health J. 2018;11(1):99–107. doi:10.1016/j.dhjo.2017.04.008
   Web of Science ®Google Scholar
• Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology. 1999;53(5):1098–1103. doi:10.1212/WNL.53.5.1098
   PubMed Web of Science ®Google Scholar
• Coyle PK, Khatri B, Edwards KR, et al. Patient-reported outcomes in relapsing forms of MS: real-world, global treatment experience with teriflunomide from the Teri-PRO study. Mult Scler Relat Disord. 2017;17:107–115. doi:10.1016/j.msard.2017.07.006
   PubMed Web of Science ®Google Scholar
• Treadaway K, Cutter G, Salter A, et al. Factors that influence adherence with disease-modifying therapy in MS. J Neurol. 2009;256(4):568–576. doi:10.1007/s00415-009-0096-y
   PubMed Web of Science ®Google Scholar
• Twork S, Nippert I, Scherer P, Haas J, Pohlau D, Kugler J. Immunomodulating drugs in multiple sclerosis: compliance, satisfaction and adverse effects evaluation in a German multiple sclerosis population. Curr Med Res Opin. 2007;23(6):1209–1215. doi:10.1185/030079907X188125
   PubMed Web of Science ®Google Scholar
• Nicolucci A, Cucinotta D, Squatrito S, et al. Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2009;19(1):45–53. doi:10.1016/j.numecd.2007.12.005
   PubMed Web of Science ®Google Scholar
• Khanna PP, Shiozawa A, Walker V, et al. Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting. Patient Prefer Adherence. 2015;9:971–981. doi:10.2147/PPA.S83700
   PubMed Web of Science ®Google Scholar
• Al-Jabi SW, Zyoud SH, Sweileh WM, et al. Relationship of treatment satisfaction to health-related quality of life: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Expect. 2015;18(6):3336–3348. doi:10.1111/hex.12324
   Web of Science ®Google Scholar
• Delestras S, Roustit M, Bedouch P, et al. Comparison between two generic questionnaires to assess satisfaction with medication in chronic diseases. PLoS One. 2013;8(2):e56247. doi:10.1371/journal.pone.0056247
   Web of Science ®Google Scholar
• Chen H, Rosenzweig EB, Gotzkowsky SK, Arneson C, Nelsen AC, Bourge RC. Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension. Health Qual Life Outcomes. 2013;11(1):31. doi:10.1186/1477-7525-11-31
   Google Scholar
• Hermann BP, Vickrey B, Hays RD, et al. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res. 1996;25(2):113–118. doi:10.1016/0920-1211(96)00024-1
   PubMed Web of Science ®Google Scholar
• Rezapour A, Almasian Kia A, Goodarzi S, Hasoumi M, Nouraei Motlagh S, Vahedi S. The impact of disease characteristics on multiple sclerosis patients’ quality of life. Epidemiol Health. 2017;39:e2017008. doi:10.4178/epih.e2017008
   PubMed Web of Science ®Google Scholar
• Ziemssen T. Multiple sclerosis beyond EDSS: depression and fatigue. J Neurol Sci. 2009;277(Suppl 1):S37–S41. doi:10.1016/S0022-510X(09)70011-5
   PubMed Web of Science ®Google Scholar
• Barin L, Salmen A, Disanto G, et al. The disease burden of multiple sclerosis from the individual and population perspective: which symptoms matter most? Mult Scler Relat Disord. 2018;25:112–121. doi:10.1016/j.msard.2018.07.013
   PubMed Web of Science ®Google Scholar
• Jongen PJ. Health-related quality of life in patients with multiple sclerosis: impact of disease-modifying drugs. CNS Drugs. 2017;31(7):585–602. doi:10.1007/s40263-017-0444-x
   PubMed Web of Science ®Google Scholar